Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants.
TENSIVE has raised $23.2M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2026.
TENSIVE's investors include European Investment Bank, UniCredit, Panakes Partners, European Innovation Council, Invitalia Ventures.
TENSIVE is headquartered in Milano, Italy.
Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to substitute silicone implants.
TENSIVE is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TENSIVE — Funding & Investors." VCBacked, September 3, 2026, https://www.vcbacked.co/company/tensive. Accessed October 17, 2026.
VCBacked. (2026). TENSIVE — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/tensive
{{cite web |title=TENSIVE — Funding & Investors |url=https://www.vcbacked.co/company/tensive |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated